# Algorithmic Biologics

> Algorithmic Biologics is a Bengaluru- and Delaware-based deep-tech company that treats molecular testing as an information-processing problem. Founded by molecular-computing researcher Dr. Manoj Gopalkrishnan, its patented Tapestry platform uses compressed sensing and combinatorial pooling to run large-scale DNA/RNA/protein tests with far fewer reactions - screening many samples at once and only zooming in where a signal exists. The approach first proved itself as an award-winning, regulator-approved COVID-19 pooling solution and now targets affordable genomics, multiplexed diagnostics, and accelerated assay design.

- **Founded:** 2021
- **Headquarters:** Bengaluru, India (with a US office in Delaware / California)
- **Founders:** Manoj Gopalkrishnan (Founder & CEO)
- **Team size:** 17 employees (LinkedIn range 11-50)
- **Products:** Tapestry, Sequence Transduction, Affordable genomics / library-prep reduction
- **Notable:** Only indigenous Indian technology to reach the finals of the XPRIZE for Rapid COVID Testing, DCGI-approved and CE-certified algorithmic solution for large-scale COVID-19 testing, Validated on 15,000+ samples at reputed Indian and international labs

## Products & services

- **Tapestry** — A cloud-delivered, single-round quantitative pooling platform that combines compressed sensing and combinatorial group testing. It lets labs pool many samples into a few pools, run them on standard assays and machines, and computationally deconvolute the results - testing e.g. 1,000 samples with ~100 reactions.
- **Sequence Transduction** — A compression architecture for multiplexed assay design that speeds development of new assays - the company cites launching 5x more assays at roughly 10x lower cost, cutting typical development timelines from ~18 months to ~3 months.
- **Affordable genomics / library-prep reduction** — Applying the platform to next-generation sequencing workflows to eliminate an estimated 60-90% of library-preparation costs, lowering the price of transcriptomics and large-scale sequencing.

## Achievements

- Only indigenous Indian technology to reach the finals of the XPRIZE for Rapid COVID Testing
- DCGI-approved and CE-certified algorithmic solution for large-scale COVID-19 testing
- Validated on 15,000+ samples at reputed Indian and international labs
- 8 patents across 5 jurisdictions
- Featured in Nature, IEEE and other scientific publications
- NASSCOM Emerge 50 winner

## Latest updates

- **2024-02** — Announced technology to make genomics affordable by eliminating 60-90% of NGS library-preparation costs; closed $2.5M seed round led by Bharat Innovation Fund.
- **2022-01** — Received seed funding from Axilor Lab to build out its molecular-programming platform.

## Links

- Website: https://algorithmicbiologics.com
- LinkedIn: https://www.linkedin.com/company/algorithmic-biologics-pvt-ltd
- YouTube: https://www.youtube.com/watch?v=C6G4ap-r8WA

---

Profile page: https://yespress.io/algorithmic-biologics
Published by YesPress — https://yespress.io
Last updated: 2026-07-07